09/14/2012
The expansion and refinement of PCR and serology panels could one day replace the need for sentinel animals.
08/13/2012
Mad Money host Jim Cramer recently interviewed Charles River CEO James Foster.
07/12/2012
Foster Jordan, Corporate Senior Vice President, Endotoxin and Microbial Detection, Charles River discusses QC testing and why it is so important in the pharmaceutical industry.
06/01/2012
Earlier in the drug development process, providers are finally seeing an uptick in sponsor demand for specialized services, after paring away at excess capacity and trying to right-size preclinical operations.
05/18/2012
Preclinical studies of stem cell therapies are critical for FDA approval to begin clinical trials, but there currently are no guidelines that address this important area of preclinical research.
05/07/2012
Charles River Senior Scientific Director Susan Y. Smith discussed the skeleton’s function in human physiology in Emerging Insights into the Role of the Skeleton, featured in a recent edition of GEN.
05/01/2012
Strategic partnerships offer a mutually beneficial approach to drug development.
04/23/2012
EMD Millipore and Charles River will integrate the TrueSpike™ technology into viral clearance services provided by Charles River, which is designed to result in a more predictable and consistent study outcome for clients, ultimately helping to improve drug product safety.
03/30/2012
Kathleen Pritchett-Corning, director of research and professional services for Charles River, and postdoctoral scientist Brianna Gaskill weigh in on the importance of lab mice nesting behavior in Keeping Chilly Lab Mice Warm...
03/02/2012
Representatives from leading contract research organizations (CROs) weigh in on key challenges tied to the biopharmaceutical R&D, including issues regarding bioequivalence, platform technologies, process analytics, and more.